Pfizer wins dismissal of U.S. investor class action ahead of trial
July 08, 2014 at 20:27 PM EDT
NEW YORK, July 8 (Reuters) - Pfizer Inc won the dismissal Tuesday of a long-running shareholder class action accusing the company of misleading investors about the safety of its Celebrex and Bextra pain-relieving drugs.
